Research Paper Volume 16, Issue 1 pp 389—401
The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients
Figure 5. (A) The relationship between PMI and OS in TAE or TACE treated HCC patients; (B) The relationship between myosteatosis and OS in TAE or TACE treated HCC patients.